Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study. (2022)
Attributed to:
MRC Lifecourse Epidemiology Centre - Core Support
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00198-022-06413-y
PubMed Identifier: 35524068
Publication URI: http://europepmc.org/abstract/MED/35524068
Type: Journal Article/Review
Volume: 33
Parent Publication: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Issue: 8
ISSN: 0937-941X